‘We actually don’t know much’: the scientists trying to close the knowledge gap in trans healthcare

When Cameron Whitley was diagnosed with kidney failure seven years ago, the news came as a shock. But the situation was about to get worse. His doctor decided the diagnosis meant Whitley’s hormone therapy had to stop.

As a transgender man, now 42, who had taken testosterone for 10 years, the impact was brutal.

“Not only was I struggling with this new diagnosis that I’m in stage four kidney failure, now I’m being told that I can no longer have hormones,” said Whitley, an associate professor in the department of sociology at Western Washington University. “I cannot describe how horrible that moment was.”